Ex Vivo Intra-arterial Indigo Carmine Injection After Transanal Total Mesorectal Excision
- Conditions
- Rectal Neoplasms
- Interventions
- Other: injection of indigo carmine
- Registration Number
- NCT04455737
- Lead Sponsor
- Walter Brunner
- Brief Summary
Background: An exact lymph node staging is essential in the treatment of rectal cancer.
Objective: The aim of this study was to assess the effect of indigo carmine injection on the number of retrieved and positive lymph nodes after transanal total mesorectal excision (taTME).
Design: This is a retrospective, non-randomised study. Settings: This study was conducted at a tertiary hospital by a multidisciplinary team.
Patients: Between 2013 and 2019, patients undergoing transanal total mesorectal excision were analysed. Patients with indigo carmine injection (intervention group) were compared to those without (control group).
Interventions: Transanal total mesorectal excision was performed with or without ex vivo intra-arterial indigo carmine injection.
Main Outcome Measures: The number of retrieved and positive lymph nodes was the primary outcome measure.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 189
- elective, oncologic rectum resection in TaTME technique for proven or highly suspected rectal cancer.
- abdominoperineal resection
- extended colon resection
- previous surgery of the rectum, the left colon or the mesocolon/-rectum
- patients rejecting retrospective data analysis
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients with indigo carmine stained specimen injection of indigo carmine Specimen which underwent pathologic work-up after ex vivo indigo carmine injection into the inferior mesenteric artery after transanal total mesorectal excision.
- Primary Outcome Measures
Name Time Method retrieved lymph nodes 1 - 7 days after surgery number of lymph nodes retrieved by pathologist from the specimen
- Secondary Outcome Measures
Name Time Method N stage 1 - 7 days after surgery N stage according TNM version 7
survival 5 years overall survival
positive lymph nodes 1 - 7 days after surgery number of lymph nodes with microscopic tumor infiltration
Trial Locations
- Locations (1)
Department of General, Visceral, Endocrine and Transplantation Surgery, Cantonal Hospital St. Gallen
🇨ðŸ‡Rorschach, Switzerland